FDA Inspection
Novitium Pharma LLCFDA Inspection 1230049 - Novitium Pharma LLC - February 16, 2024
Record Details
This FDA Inspection record concerns Novitium Pharma LLC, with an inspection on February 16, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c4edb0db-e08e-4305-9915-71b848ff4d32
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1230049
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Novitium Pharma LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 1, 2024 | Not classified | New Jersey District Office | |
| March 31, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 8, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 4, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 9, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novitium Pharma LLC
- FDA Inspection 1231393 - 2024-02-01
- FDA Inspection 1204308 - 2023-03-31
- FDA Inspection 1145707 - 2021-07-08
- FDA Inspection 1080904 - 2019-02-04
- FDA Inspection 1053573 - 2018-05-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.